Treasurer of the State of North Carolina
RPRX icon

Treasurer of the State of North Carolina’s Royalty Pharma RPRX Stock Holding History

Treasurer of the State of North Carolina’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3M Buy
558,913
+14,880
+3% +$774K 0.08% 216
2026
Q1 		$26.1M Buy
544,033
+38,548
+8% +$1.69M 0.08% 219
2025
Q4 		$19.5M Sell
505,485
-8,137
-2% -$310K 0.06% 270
2025
Q3 		$18.1M Sell
513,622
-12,007
-2% -$435K 0.06% 300
2025
Q2 		$18.9M Buy
525,629
+228,440
+77% +$7.57M 0.06% 294
2025
Q1 		$9.25M Buy
297,189
+125,100
+73% +$3.97M 0.04% 412
2024
Q4 		$4.39M Sell
172,089
-10,837
-6% -$287K 0.02% 626
2024
Q3 		$5.17M Sell
182,926
-48,357
-21% -$1.34M 0.02% 585
2024
Q2 		$6.1M Buy
231,283
+55,404
+32% +$1.54M 0.03% 519
2024
Q1 		$5.34M Buy
175,879
+1,102
+0.6% +$32.5K 0.02% 569
2023
Q4 		$4.91M Buy
174,777
+1,581
+0.9% +$43.4K 0.02% 559
2023
Q3 		$4.7M Buy
173,196
+642
+0.4% +$19.1K 0.03% 542
2023
Q2 		$5.3M Buy
172,554
+4,685
+3% +$159K 0.03% 522
2023
Q1 		$6.05M Buy
167,869
+1,050
+0.6% +$38.9K 0.03% 465
2022
Q4 		$6.59M Buy
166,819
+4,500
+3% +$188K 0.04% 428
2022
Q3 		$6.52M Buy
162,319
+7,030
+5% +$300K 0.04% 411
2022
Q2 		$6.53M Buy
155,289
+35,466
+30% +$1.45M 0.04% 426
2022
Q1 		$4.67M Sell
119,823
-2,610
-2% -$102K 0.03% 532
2021
Q4 		$4.88M Buy
122,433
+130
+0.1% +$5.05K 0.03% 531
2021
Q3 		$4.42M Buy
122,303
+9,109
+8% +$354K 0.03% 546
2021
Q2 		$4.64M Sell
113,194
-4,410
-4% -$188K 0.03% 530
2021
Q1 		$5.13M Buy
117,604
+77,600
+194% +$3.68M 0.03% 492
2020
Q4 		$2M Buy
40,004
+8,764
+28% +$372K 0.01% 756
2020
Q3 		$1.31M Buy
+31,240
New +$1.34M 0.01% 810

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Treasurer of the State of North Carolina's RPRX Position: Q2 2026 in Review

Treasurer of the State of North Carolina increased its Royalty Pharma (RPRX) stake by 2.7% in Q2 2026, buying an estimated $774K and bringing the position to 558,913 shares worth $31.3M. The position accounts for 0.08% of the portfolio, ranked #216.

Treasurer of the State of North Carolina first reported a position in RPRX in Q3 2020 and has held it in 24 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Treasurer of the State of North Carolina held 558,913 shares of Royalty Pharma worth $31.3M as of Q2 2026.
  • Treasurer of the State of North Carolina bought 14,880 Royalty Pharma shares in Q2 2026, an estimated $774K.
  • Royalty Pharma made up 0.08% of Treasurer of the State of North Carolina's portfolio in Q2 2026, its #216 holding.
  • Treasurer of the State of North Carolina first reported a position in Royalty Pharma in Q3 2020 and has held it in 24 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2026, filed 14 Aug 2026.